What is the dosage of Gamunex?

Gamunex is available in 6 dosages, including 100 mg/ml Injection 100 ml, 100 mg/ml Injection 50 ml, 100 mg/ml Injection 400 ml, 100 mg/ml Injection 10 ml, 100 mg/ml Injection 25 ml and 100 mg/ml Injection 200 ml

What does Gamunex treat?

Gamunex treats Immunologic Deficiency Syndromes

What is Gamunex made of?

Gamunex contains immunoglobulin G which is a Human Immunoglobulin G

How is Gamunex administered?

Gamunex is administered as a Injectable

What is Gamunex mechanism of action?

Gamunex mechanism of action is Antigen Neutralization

Gamunex - C Prescribing & Dosing Schedule

Last Update: Oct, 06 2024

Gamunex - C (immunoglobulin G, human)

gamunex-C 10 % in 10 mL Injection

BOXED WARNING

Dosage & Administration

Intravenous Administration Only: ITP and CIDP

Indication	Dose	Initial Infusion Rate	Maintenance Infusion Rate (if tolerated)
ITP	2 g/kg	1 mg/kg/min	8 mg/kg/min
CIDP	loading dose 2 g/kg maintenance dose 1 g/kg	2 mg/kg/min	8 mg/kg/min Every 3 weeks

* Ensure that patients with pre-existing renal insufficiency are not volume depleted; discontinue GAMUNEX-C if renal function deteriorates.
* For patients at risk of renal dysfunction or thrombosis, administer GAMUNEX-C at the minimum infusion rate practicable.

Intravenous or Subcutaneous Administration: PI
DO NOT ADMINISTER SUBCUTANEOUSLY FOR ITP PATIENTS

* See section 2.2. * Adults: use up to 8 infusion sites simultaneously; pediatric: use up to 6 infusion sites simultaneously; for all ages, ensure infusion sites are at least 2 inches (5 cm) apart.
Route of Administration	Dose *	Initial Infusion Rate	Maintenance Infusion Rate (if tolerated)
Intravenous (IV)	300 – 600 mg/kg	1 mg/kg/min	8 mg/kg/min Every 3 to 4 weeks
Subcutaneous (SC)	1.37 x current IV dose in grams/IV dose interval in weeks	Adult: † 20 mL/hr/site Pediatric: † 10 mL/hr/site (< 25 kg) 15 mL/hr/site (≥ 25 kg)	Adult: † 20 mL/hr/site Pediatric † 10 mL/hr/site (< 25 kg) 20 mL/hr/site (≥ 25 kg) Weekly

Get Your Patient on Gamunex - C

Find restrictionsSee step therapiesCompare coverage options

Gamunex - C Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

Gamunex - C Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form

Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form

Coverage Authorization Appeals

Formulary Exception Letter

Complete Letter of Medical Necessity

Gamunex - C Preferred Pharmacy

Pharmacy List

Gamunex - C Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program: CIDP & PIDD

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

Gamunex-C Patient Assistance Program: CIDP & PIDD

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.